HIMS Hims & Hers Health
$29.47 -0.67%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-0.67%
YTD
-49.20%
P/E
52.71
P/B
13.66
ROE
-30%
Div yield
—
Beta
2.68
Market cap
$6.8B
RSI (14)
52
Next earnings
Nov 2, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$30.08
Close
$29.47
VWAP (n/a)
—
Day high
$30.08
Day low
$29.07
Volume
8.8M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Arboretum Launches to Redefine Precision Medicine for Common Diseases as a Next-Generation Molecular Information Company
Yahoo Finance · Oct 6
How Investors May Respond To Hims & Hers Health (HIMS) Appointing Regional Chief Medical Officers For Global Expansion
Yahoo Finance · Oct 5
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
Yahoo Finance · Oct 5
Hims & Hers Health, Inc. (HIMS) Stock Slides as Market Rises: Facts to Know Before You Trade
Yahoo Finance · Oct 1
Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership
Yahoo Finance · Oct 1
Hims & Hers Stock: 30% Growth Can’t Hide a Margin Problem
Yahoo Finance · Sep 28
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Aug 10, 2026 View → 8-K Aug 10, 2026 View → 8-K Jul 17, 2026 View → 8-K Jul 1, 2026 View → 8-K Jun 15, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell HIMS. Try it in the Lab to size a position and see the risk.